Application
19607216 · NOVEL COMPOUND USED AS CBP/P300 INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, INFLAMMATORY DISORDERS, OR AUTOIMMUNE DISEASES COMPRISING SAME AS ACTIVE INGREDIENT
Filed 2026-07-17 · Pending The official file ↗ · Art unit · LG CHEM, LTD. · ROTHWELL, FIGG, ERNST & MANBECK, P.C.
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read